Pharmacologic treatment of depression in the elderly
- PMID: 24522673
- PMCID: PMC3922554
Pharmacologic treatment of depression in the elderly
Abstract
Objective: To discuss pharmacologic treatment of depression in the elderly, including choice of antidepressants, titration of dose, monitoring of response and side effects, and treatment of unresponsive cases.
Sources of information: The 2006 Canadian Coalition for Seniors' Mental Health guideline on the assessment and treatment of depression was used as a primary source. To identify articles published since the guideline, MEDLINE was searched from 2007 to 2012 using the terms depression, treatment, drug therapy, and elderly.
Main message: The goal of treatment should be remission of symptoms. Improvement of symptoms can be monitored by identifying patient goals or by use of a clinical tool such as the Patient Health Questionnaire-9. Treatment should be considered in 3 phases: an acute treatment phase to achieve remission of symptoms, a continuation phase to prevent recurrence of the same episode of illness (relapse), and a maintenance (prophylaxis) phase to prevent future episodes (recurrence). Initial dosing should be half of the usual adult starting dose and be titrated regularly until the patient responds, until the maximum dose is reached, or until side effects limit further increases. Common side effects of medications include falls, nausea, dizziness, headaches, and, less commonly, hyponatremia and QT interval changes. Strategies for switching or augmenting antidepressants are discussed. Older patients should be treated for at least a year from when clinical improvement is noted, and those with recurrent depression or severe symptoms should continue treatment indefinitely. Treatment of specific situations such as severe depression or depression with psychosis is discussed, including the use of electroconvulsive therapy. Criteria for referral to geriatric psychiatry are provided; however, many family physicians do not have easy access to this resource or to other nonpharmacologic clinical strategies.
Conclusion: The effectiveness of pharmacologic treatment of depression is not substantially affected by age. Identification of depression, choice of appropriate treatment, titration of medications, monitoring of side effects, and adequate duration of treatment will improve outcomes for older patients.
Similar articles
-
Co-occurring depressive symptoms in the older patient with schizophrenia.Drugs Aging. 2008;25(8):631-47. doi: 10.2165/00002512-200825080-00002. Drugs Aging. 2008. PMID: 18665657 Free PMC article. Review.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Two-year outcome of psychotic depression in late life.Am J Psychiatry. 1998 Feb;155(2):178-83. doi: 10.1176/ajp.155.2.178. Am J Psychiatry. 1998. PMID: 9464195 Clinical Trial.
-
[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].Encephale. 2003 Sep-Oct;29(5):438-44. Encephale. 2003. PMID: 14615693 French.
-
Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27. CNS Spectr. 2007. PMID: 17986951 Review.
Cited by
-
Humanoid robot intervention vs. treatment as usual for loneliness in long-term care homes: Study protocol for a pilot randomized controlled trial.Front Psychiatry. 2022 Oct 21;13:1003881. doi: 10.3389/fpsyt.2022.1003881. eCollection 2022. Front Psychiatry. 2022. PMID: 36339874 Free PMC article.
-
A Case Study on Polypharmacy and Depression in a 75-Year-Old Woman with Visual Deficits and Charles Bonnet Syndrome.Geriatrics (Basel). 2021 Dec 28;7(1):5. doi: 10.3390/geriatrics7010005. Geriatrics (Basel). 2021. PMID: 35076477 Free PMC article.
-
Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service.Curr Psychiatry Rep. 2020 Apr 13;22(5):21. doi: 10.1007/s11920-020-01147-2. Curr Psychiatry Rep. 2020. PMID: 32285305 Review.
-
A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch.Case Rep Psychiatry. 2019 Dec 8;2019:2890913. doi: 10.1155/2019/2890913. eCollection 2019. Case Rep Psychiatry. 2019. PMID: 31886000 Free PMC article.
-
Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation.Front Genet. 2019 Sep 20;10:898. doi: 10.3389/fgene.2019.00898. eCollection 2019. Front Genet. 2019. PMID: 31616477 Free PMC article. Review.
References
-
- Canadian Coalition for Seniors’ Mental Health. National guidelines for seniors’ mental health. Toronto, ON: Canadian Coalition for Seniors’ Mental Health; 2006.
-
- Korten NC, Comijs HC, Lamers F, Penninx BW. Early and late onset depression in young and middle aged adults: differential symptomatology, characteristics and risk factors? J Affect Disord. 2012;138(3):259–67. - PubMed
-
- George K, Davison TE, McCabe M, Mellor D, Moore K. Treatment of depression in low-level residential care facilities for the elderly. Int Psychogeriatr. 2007;19(6):1153–60. - PubMed
-
- Harris T, Carey IM, Shah SM, DeWilde S, Cook DG. Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales. J Am Med Dir Assoc. 2012;13(1):41–7. - PubMed
-
- MacArthur Initiative on Depression and Primary Care. Patient health questionnaire. Hanover, NH: MacArthur Initiative on Depression and Primary Care; 2012. Available from: www.depression-primarycare.org/clinicians/toolkits/materials/forms/phq9. Accessed 2012 Dec 5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials